Literature DB >> 1656100

Transcription factor AP-1 modulates the activity of the human foamy virus long terminal repeat.

B Maurer1, E Serfling, V ter Meulen, A Rethwilm.   

Abstract

The human foamy virus (HFV) contains within the U3 region of its long terminal repeat (LTR) three perfect consensus sequences for the binding of the inducible transcription factor AP-1. Results of DNase I footprint protection and gel retardation assays demonstrated that proteins in extracts of HeLa and BHK-21 cells as well as bacterially expressed Jun and Fos proteins bind to these AP-1 sites. By conducting transient expression assays using chloramphenicol acetyltransferase plasmids carrying LTR sequences with point-mutated AP-1 sites, it was found that the three AP-1 sites contribute to the optimal activity of the HFV promoter. It is shown that induction of the HFV LTR by 12-O-tetradecanoylphorbol-13-acetate (TPA) and serum factors is mediated through the AP-1 sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656100      PMCID: PMC250355     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP.

Authors:  M Imagawa; R Chiu; M Karin
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

2.  Characterization of the transcriptional trans activator of human foamy retrovirus.

Authors:  A Keller; K M Partin; M Löchelt; H Bannert; R M Flügel; B R Cullen
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

Authors:  P Angel; M Imagawa; R Chiu; B Stein; R J Imbra; H J Rahmsdorf; C Jonat; P Herrlich; M Karin
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

5.  Cleavage of procaryotically expressed human immunodeficiency virus fusion proteins by factor Xa and application in western blot (immunoblot) assays.

Authors:  S Ellinger; R Glockshuber; G Jahn; A Plückthun
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

6.  Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters.

Authors:  A Schönthal; P Herrlich; H J Rahmsdorf; H Ponta
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

7.  Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activation.

Authors:  J L Hess; J A Small; J E Clements
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

8.  Identification of the simian foamy virus transcriptional transactivator gene (taf).

Authors:  A Mergia; K E Shaw; E Pratt-Lowe; P A Barry; P A Luciw
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  Genomic organization of the human spumaretrovirus and its relatedness to AIDS and other retroviruses.

Authors:  B Maurer; R M Flügel
Journal:  AIDS Res Hum Retroviruses       Date:  1988-12       Impact factor: 2.205

10.  Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus.

Authors:  B Maurer; H Bannert; G Darai; R M Flügel
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

View more
  11 in total

1.  Cell-type-specific regulation of the two foamy virus promoters.

Authors:  C D Meiering; C Rubio; C May; M L Linial
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  In vitro infection of primary and retrovirus-infected human leukocytes by human foamy virus.

Authors:  J A Mikovits; P M Hoffman; A Rethwilm; F W Ruscetti
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  Characterization of the internal promoter of simian foamy viruses.

Authors:  M Campbell; L Renshaw-Gegg; R Renne; P A Luciw
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Structure and function of the long terminal repeat of the chimpanzee foamy virus isolates (SFV-6).

Authors:  J De Celis; J Tobaly-Tapiero; A Hampe; R Emanoil-Ravier
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  Isolation of novel human endogenous retrovirus-like elements with foamy virus-related pol sequence.

Authors:  A Cordonnier; J F Casella; T Heidmann
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

6.  Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice.

Authors:  A Aguzzi; E F Wagner; K O Netzer; K Bothe; I Anhauser; A Rethwilm
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

7.  Multiple positive and negative cis-acting elements that mediate transactivation by bel1 in the long terminal repeat of human foamy virus.

Authors:  K J Lee; A H Lee; Y C Sung
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay.

Authors:  S F Yu; M L Linial
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1.

Authors:  K A Roebuck; D A Brenner; M F Kagnoff
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for viral replication.

Authors:  Laurence Colin; Nathalie Vandenhoudt; Stéphane de Walque; Benoît Van Driessche; Anna Bergamaschi; Valérie Martinelli; Thomas Cherrier; Caroline Vanhulle; Allan Guiguen; Annie David; Arsène Burny; Georges Herbein; Gianfranco Pancino; Olivier Rohr; Carine Van Lint
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.